The Zambon Group Overview
- Year Founded
-
1906
- Status
-
Private
- Employees
-
2,700
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$64.2M
The Zambon Group General Information
Description
Manufacturer of pharmaceutical and chemical products designed to support health care and drug development. The company offers active pharmaceutical ingredients, advanced intermediates, contract manufacturing services, and integrated research capabilities, enabling pharmaceutical firms and biotech developers to improve production efficiency and therapeutic innovation.
Contact Information
Website
www.zambon.comCorporate Office
- Via Lillo del Duca, 10
- 20091 Bresso(Milan)
- Italy
Corporate Office
- Via Lillo del Duca, 10
- 20091 Bresso(Milan)
- Italy
The Zambon Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Debt - General | 01-Dec-2012 | $64.2M | Completed | Generating Revenue |
The Zambon Group Comparisons
Industry
Financing
Details
The Zambon Group Competitors (51)
One of The Zambon Group’s 51 competitors is AltaThera Pharmaceuticals, a Private Equity-Backed company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AltaThera Pharmaceuticals | Private Equity-Backed | Chicago, IL | ||||
| Menarini Group | Corporation | Florence, Italy | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy |
The Zambon Group Patents
The Zambon Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025237808-A1 | Orodispersible pharmaceutical compositions comprising an amino acid salt of ibuprofen | Pending | 14-May-2024 | ||
| AU-2023274384-A1 | Antimicrobial association in the treatment of p. aeruginosa biofilm-associated infections | Pending | 27-May-2022 | ||
| EP-4531835-A1 | Antimicrobial association in the treatment of p. aeruginosa biofilm-associated infections | Pending | 27-May-2022 | ||
| US-20250325625-A1 | Antimicrobial association in the treatment of p. aeruginosa biofilm-associated infections | Pending | 27-May-2022 | ||
| WO-2023227673-A1 | Antimicrobial association in the treatment of p. aeruginosa biofilm-associated infections | Inactive | 27-May-2022 | A61K38/12 |
The Zambon Group Signals
The Zambon Group Investments & Acquisitions (14)
The Zambon Group’s most recent deal was a Accelerator/Incubator with Kadence for . The deal was made on 23-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kadence | 23-Sep-2024 | Accelerator/Incubator | Drug Discovery | ||
| Hyivy | 19-Jul-2024 | Seed Round | Therapeutic Devices | ||
| Breath Therapeutics | 25-Jul-2019 | Merger/Acquisition | Drug Discovery | ||
| Plusimple | 22-Oct-2017 | Accelerator/Incubator | Other Healthcare Technology Systems | ||
| Savara | 06-Jun-2017 | Public Investment 2nd Offering | Drug Discovery |
The Zambon Group Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Open Accelerator | Milan, Italy | 2016 | |
| Zetacube S.R.L. O In Forma Abbreviata O Commerciale Z-Cube | Bresso, Italy | 2006 | |
| Zcube | Milan, Italy | 2003 | |
| Italiassistenza | Reggio Emilia, Italy | 1993 | |
| Laboratoires Laphal | Allauch, France | 1970 |
The Zambon Group FAQs
-
When was The Zambon Group founded?
The Zambon Group was founded in 1906.
-
Where is The Zambon Group headquartered?
The Zambon Group is headquartered in Bresso, Italy.
-
What is the size of The Zambon Group?
The Zambon Group has 2,700 total employees.
-
What industry is The Zambon Group in?
The Zambon Group’s primary industry is Drug Discovery.
-
Is The Zambon Group a private or public company?
The Zambon Group is a Private company.
-
What is The Zambon Group’s current revenue?
The current revenue for The Zambon Group is .
-
How much funding has The Zambon Group raised over time?
The Zambon Group has raised $64.2M.
-
Who are The Zambon Group’s competitors?
AltaThera Pharmaceuticals, Menarini Group, Genentech, Pfizer (Vienna), and Chiesi Farmaceutici are some of the 51 competitors of The Zambon Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process